Interestingly, Rajagopal found that heterozygous genotype (TM) and homozygous mutant genotype (MM) were not significantly associated with breast cancer risk when it comes to the role of the T241M variation in XRCC3 (48). This evidence concerns the gene XRCC3 and breast carcinoma.